MEI Pharma Inc logo

MEI Pharma Inc

NAS:MEIP (USA)  
$ 4.00 +0.08 (+2.04%) 11:08 PM EST
1.35
P/B:
0.45
Market Cap:
$ 26.65M
Enterprise V:
$ -20.80M
Volume:
13.33K
Avg Vol (2M):
22.84K
Also Trade In:
Volume:
13.33K
Avg Vol (2M):
22.84K

Business Description

Description
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

Financials (Next Earnings Date:2024-05-10 Est.)

MEIP's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MEIP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

MEI Pharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 72.648
EPS (TTM) ($) 2.97
Beta -0.01
Volatility % 76.72
14-Day RSI 49.08
14-Day ATR ($) 0.265729
20-Day SMA ($) 3.8806
12-1 Month Momentum % -7.57
52-Week Range ($) 3.4601 - 7.97
Shares Outstanding (Mil) 6.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MEI Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

MEI Pharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

MEI Pharma Inc Frequently Asked Questions

What is MEI Pharma Inc(MEIP)'s stock price today?
The current price of MEIP is $4.00. The 52 week high of MEIP is $7.97 and 52 week low is $3.46.
When is next earnings date of MEI Pharma Inc(MEIP)?
The next earnings date of MEI Pharma Inc(MEIP) is 2024-05-10 Est..
Does MEI Pharma Inc(MEIP) pay dividends? If so, how much?
MEI Pharma Inc(MEIP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1